Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hormone Therapy in Postmenopausal Women and Risk of Endometrial Hyperplasia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Intravenous_immunoglobulins_for_multiple_sclerosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 28 March 2024.
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Intravenous_immunoglobulins_for_multiple_sclerosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed March 28, 2024.
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Intravenous_immunoglobulins_for_multiple_sclerosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Hormone Therapy in Postmenopausal Women and Risk of Endometrial Hyperplasia [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Intravenous_immunoglobulins_for_multiple_sclerosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
ID - 431390
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Intravenous_immunoglobulins_for_multiple_sclerosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -